Amol Akhade/LinkedIn
Apr 26, 2025, 00:17
Amol Akhade: Excited for the positive news on PFS for Destiny 09
Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared a post on LinkedIn:
“Excited for the positive news on PFS for Destiny 09.
Any predictions on HR for PFS? ( my bet is on close to 0.5 for combination of Enhertu plus Pertuzumab)
The press release focuses on Enhertu plus Pertuzumab vs THP. Eagerly awaiting the complete dataset.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 12, 2025, 07:46
May 12, 2025, 07:39
May 12, 2025, 07:37
May 12, 2025, 07:34
May 12, 2025, 05:08
May 12, 2025, 04:22